Navigation Links
Varian Medical Systems to Introduce RapidArc(TM) Radiotherapy Technology for Volumetric Arc Therapy at ASTRO 2007
Date:10/25/2007

aid Corey Zankowski, senior director of software systems marketing at Varian Medical Systems.

* Varian is aiming to make RapidArc available for radiation clinics in Spring 2008. As a product pending FDA 510(k) clearance, it is not yet available for sale in the United States. For more information, high resolution photos, and other news about Varian at the ASTRO meeting, visit the company's ASTRO newsroom page at this URL: http://varian.mediaroom.com/index.php?s=pageC.

ABOUT VARIAN MEDICAL SYSTEMS

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,500 people who are located at manufacturing sites in North America and Europe and approximately 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

FORWARD-LOOKING STATEMENTS

Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "will enable," "we can," and "can now start" constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause ac
'/>"/>

SOURCE Varian Medical Systems
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ovarian cancer in relationship with Hormone therapy
2. Vitamin D Reduces Chances of Colon, Breast And Ovarian Cancers by 50%
3. Progestin protects against ovarian cancer
4. Inherited gene important in ovarian cancer
5. Blood test may identify ovarian cancer
6. Exercise lowers Risk of Ovarian Cancer
7. Screening device for ovarian cancer
8. Ethnic discrepancy in ovarian cancer
9. Gene variant foretells diabetic neuropathy
10. Associated scan for detecting ovarian cancer spread
11. Gene Mutation Causes Ovarian Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Newswire/ -- NursingCenter.com, the premier site,...eviewed content, has been,updated to improve the ...,users. Powered by Lippincott Williams & Wilki... peer-reviewed continuing education activities and... leading nursing journals.,Lippincott Williams &a...
(Date:11/21/2008)...PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc...ders overwhelmingly approved the proposals submitt...Teva Pharmaceuticals Industries Ltd. (Nasdaq: TE...verwhelming support of the transaction by the Barr...man and CEO. "We are pleased with the progress tha...
(Date:11/21/2008)...swire/ -- For the second year in a row and the t...are Worldwide,s agency network won more creative a...nual international RX Club Show. , , Nine ...otal of 59 RX Club Awards of Excellence, including...are Worldwide agencies include Caudex Medical, ech...
(Date:11/21/2008)... The University of Texas M. D. Anderson Cancer Cen... to eradicate breast cancer in Panama through the ...ch of the Americas today at an event with Laura Bu...n Fernndez de Torrijos, the First Lady of Panama. ... the U.S. Department of State and Susan G. Komen f...
Breaking Medicine News(10 mins):Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2
... of coffee at breakfast may be making an individua...d a study to determine how caffeine impacts blood ...ne suggest, // drinking two cups of instant coffee...n men with type 2 diabetes. More recent studies ha...
...study done on the risks and benefits of short-term... found that women can // increase their quality of...ancy if they use hormone therapy. Deciding whethe... difficult decision. Hormone therapy can be an eff...
...arly does a child have to be born if it starts to ...bstetricians would answer differently.// A new stu...nefits of delaying the birth. The study finds even...a disability for the baby. Until now, no study has...
...rchers say nearly one-third of patients don’t get ...fter a hospitalization for systolic heart failure,...g blood. // According to their research they say ...sin-converting enzyme inhibitor are 14-percent mor...
Other Medicine News:
(Date:11/19/2008)...9 Posit Science Corporation,resea...ty for Neuroscience,Annual Conference in Washingt...ng may benefit Baby Boomers. The computerized bra...es adaptive exercises that target auditory and,la...ve generalized,improvements in cognition by impro...
(Date:11/19/2008)... not achieve statistical significance , , I...armos Corporation (Nasdaq: PARS ) today announce...topical NanoEmulsion (NE) drug delivery technology... , The multi-center, randomized, double-blind...and efficacy of the Company,s 3% Diclofenac Dietha...
(Date:11/19/2008)...ov. 19 Biotech scientists increasi...ogy research to better understand the effects of n..., reports Genetic Engineering & Biotechnology...figuring out a new compound,s mechanism of action ...technique, according to the November 15 issue of ...
(Date:11/19/2008)...Payment from Roche- , , MONTVALE, N.J., Nov...als Corp. (Nasdaq: MEMY ) today announced that i... trial of R3487/MEM 3454, its lead alpha-7 nicotin...iated with schizophrenia (CIAS). The Company has ...gering a $5.0 million payment from its partner Roc...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 1Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 2Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 3Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 4Web Tool Aids Men in Prostate Decisions 12753 1Web Tool Aids Men in Prostate Decisions 12753 2Social Security Lifts 1 3 Million Children Out of Poverty 12751 1Social Security Lifts 1 3 Million Children Out of Poverty 12751 2Five Years of VA Health Care for Combat Veterans 12749 1Five Years of VA Health Care for Combat Veterans 12749 2
Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: